A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Clinical trial NCT01130493 · COMPLETED

Trial details

NCT number: NCT01130493
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2010-05-01
Primary completion: 2012-01-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.